MAPT and depressive symptom measurement: This study provides the first mechanistic evidence of tau pathology in the DRN of an AD model (htau) including monoaminergic neuronal loss, monoamine metabolite dysfunction, 5HT receptor dysregulation and behavioral impairments that are reminiscent of prodromal depression.